Comparison of 4 methods for quantification of dopamine transporters by SPECT with [123I]IACFT

Journal of Nuclear Medicine

Volumn 41, Issue 6, 2000, Pages 1086-1092

  Bonab, Ali A ^b   Fischman, Alan J ^b   Alpert, Nathaniel M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

Brain SPECT; Dopamine transporter; Kinetic modeling; Parkinson's disease; SPECT quantification

Indexed keywords

ALTROPANE; DOPAMINE TRANSPORTER; IODINE 123;

ADULT; AGED; ARTICLE; BINDING AFFINITY; CHROMATOGRAPHY; CLINICAL ARTICLE; DOPAMINE UPTAKE; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIGAND BINDING; MALE; MATHEMATICAL ANALYSIS; OCCIPITAL CORTEX; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGED; BRAIN; CARRIER PROTEINS; CORPUS STRIATUM; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IODINE RADIOISOTOPES; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; OCCIPITAL LOBE; PARKINSON DISEASE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 0034086146     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. 123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates. Synapse. 1993;13:295-309.
2. 123I]beta-CIT binding to dopamine transporters in healthy human subjects. J Cereb Blood Flow Metab. 1994;14:982-994.
3. 3H]imipramine. J Pharmacol Exp Ther. 1987;242:364-371.
4. 11C-CFT. Synapse. 1996;24:262-272.
5. 123I]CIT. Eur J Pharmacol. 1991;200:369-370.
6. 99mTc]TRODAT-1: dopamine transporter imaging agent. J Nucl Med. 1999;40:150-158.
7. 123I]FPCIT SPECT. J Nucl Med. 1999;40:735-761.
8. 123I]beta-CIT in human plasma may obstruct quantitation of the dopamine transporter. Synapse. 1995;19:297-300.
9. Elmaleh DR, Fischman AJ, Shoup TM, et al. Preparation and biological evaluation of iodine-125-IACFT: a selective SPECT agent for imaging dopamine transporter sites. J Nucl Med. 1996;37:1197-1202.
10. Bonab AA, Bahich JW, Alpert NM, Madras BK, Fischman AJ. Comparison of 3 methods for quantification of dopamine transporters by SPECT wild I-123 altropane [abstract]. J Nucl Med. 1997;5(suppl):223P.
11. Fischman AJ, Babich JW, Elmaleh DR, et al. SPECT imaging of dopamine transporter sites in normal and MPTP treated rhesus monkeys. J Nucl Med. 1996;37:1197-1202.
12. Madras BK, Gracz LM, Meltzer PC, et al. Altropane, a SPECT or PET imaging probe for dopamine neurons: I. Dopamine transporter binding in primate brain. Synapse. 1998;29:93-104.
13. Madras BK, Gracz LM, Meltzer PC, et al. Altropane, a SPECT or PET imaging probe for dopamine neurons: II. Distribution to dopamine-rich regions of primate brain. Synapse. 1998;29:105-115.
14. Madras BK, Gracz LM, Kaufman MJ, et al. Altropane, a SPECT or PET imaging probe for dopamine neurons: III. Human dopamine transporter in postmortem normal and Parkinson's disease brain. Synapse. 1998;29:116-127.
15. Fischman AJ, Bonab AA, Babich JW, et al. Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters. Synapse. 1998;29:128-141.
16. 2-dopamine receptors studied by PET: a comparison to the equilibrium analysis. J Cereb Blond Flow Metab. 1989;9:696-708.
17. Gunn RN, Lammertsma AA, Cunningham VJ. Parametric imaging of ligand-receptor interaction using a reference tissue model. Neuroimage. 1997;6:279-287.
18. Chang L. A method lor attenuation correction in computed tomography. IEEE Trans Nucl Sci. 1987;25:638-643.
19. 11C-methyl-(-)-cocaine PET studies. J Cereb Blood Flow Metab. 1990;10:740-747.
20. Jchise M, Ballinger JR, Golan H, et al, Noninvasivc quantification of D2 receptors with iodine-123-IBF SPECT. J Nucl Med. 1996;37:513-520.
21. Logan J, Fowler J, Volkow ND, Wang G, Ding Y, Alexoff DL. Distribution volume ratio without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab. 1996;16:834-840.